TABLE 1.
Peptide | Name | Model | FC(Model/Control) | DF | FC (DF/Model) | OPZ | FC (OPZ/Model) |
---|---|---|---|---|---|---|---|
DIVYIGLR | Arg1 | ↑# | 2.28 | ↓** | 0.47 | Statistically Insignificant | 1.44 |
ANEELAGVVAEVQK | Arg1 | ↑# | 1.93 | ↓* | 0.41 | Statistically Insignificant | 1.37 |
DLFDPIIQDR | Ckm | ↑### | 1.92 | ↓* | 0.48 | Statistically Insignificant | 0.57 |
VLTPDLYNK | Ckm | ↑### | 2.11 | ↓** | 0.55 | Statistically Insignificant | 0.46 |
SYALCVPLAPGEGCGPR | Cmpk2 | ↓## | 0.60 | ↑* | 1.86 | ↑** | 1.78 |
IAAQTLLGTAK | Pycr3 | ↓# | 0.44 | ↑** | 1.98 | ↑** | 1.93 |
GLGLSPDLIVCR | Ctps2 | ↑### | 1.79 | ↓** | 0.47 | ↓* | 0.37 |
# p < 0.05, ## p < 0.01, ### p < 0.001 compared with control; *p < 0.05, **p < 0.01, ***p < 0.001 compared with model; “↑”, increase in signal; “↓”, decrease in signal; Data are expressed as mean ± SD (n = 5).